symp1

0

J.-R. Claude (France): Safety pharmacology in the non clinical assessment of new medicinal products: place, interest and difficulties.

K. Olejniczak (Germany): The ICH note for guidance.

P. Spindler (Denmark): The GLP requirements in safety pharmacology.

C. Rochat (France): Strategy for safety pharmacology studies in the course of the clinical development.

G. Bode (Germany): Safety pharmacology studies in the course of toxicology studies.